Advancing health and social care real-world impact through collaboration
BMJ and Overton created BMJ Impact Analytics to address the exciting opportunities for a more in-depth understanding of medical and health research impact. Our co-development combines Overton’s data knowledge and BMJ’s health expertise to offer the only impact tool focused on health and social care.
-
It was created collaboratively and specifically for the medical and health research community
It offers the impact data and the most helpful features for this community. Overton pulls in policy documents from all topic areas and has been created for users interested in all policy impact across all subjects.
-
The breadth of health policy and clinical guidance content
BMJ’s health expertise means that the team has found and assessed the best medical and health research sources, including national guidelines from important North American associations. Many unique sources have been added, and new sources are being assessed and added continuously. This focus on health policy and clinical guidance sources means more citation results for research published in the field.
-
Curation & context
BMJ Impact Analytics’ focus on medicine and health, and BMJ’s expertise means we can plan new features that contextualise citations and mentions of research and researchers. Our roadmap includes more granular features to provide more insight into the extent of your impact.
-
Finding impact that is closer to the patient
Understanding how research influences patient care is crucial to assessing the real-world impact of medical research. With this goal, BMJ Impact Analytics has included citations in BMJ Best Practice as a data source. BMJ Best Practice is ranked as one of the best clinical decision support tools for health professionals. It is also available through epocrates, which over 1 million healthcare professionals worldwide use to inform their practice.
BMJ Impact Analytics also includes Care Pathways (interventions for mutual decision-making and organisation of care processes for patients) as another indication of this type of impact.
"BMJ Impact Analytics was developed in partnership with medical departments and funders, combining the data they need with an interface that makes it easy to find and use. We're delighted to be collaborating with BMJ and taking this important next step towards supporting a healthy, responsible impact culture in research."
Euan AdieFounder and Director of Overton